| HOME >> MEDICINE >> TECHNOLOGY |
$
(1)$
(152)Adjustments to reconcile net loss to net cashprovided by operating activities: Depreciation
234265 Amortization
437420 Stock-based compensation
411346 Increase (decrease) in allowance for doubtful accounts
2(4) Decrease in inventory obsolescence reserve
(58)(168) Gain Loss on disposal of equipment
376 Gain Loss on disposal of discontinued operations
(816)- Changes in operating assets and liabilities:Accounts receivable
96(733)Inventories
(94)115Prepaid expenses and other current assets
(33)35Accounts payable
7271Employee compensation
268(634)Deferred income
222165Warranty reserve
(50)(34)Other current liabilities and accrued expenses
221(187) Net cash provided by (used in) operating activities
914(419)Cash flows from investing activities:Sales of investments
7212,715Proceeds from sale of discontinued operations
665-Purchases of property and equipment and intangible assets
(1,131)(599) Net cash provided by investing activities
2552,116Cash flows from financing activities:Proceeds from issuance of common stock under employee stock purchase plan
5020Proceeds from the exercise of stock options
9748Repurchase of common stock
(66)(198)Repurchase of common stock upon vesting of restricted stock awards
(46)(49) Net cash provided by (used in) financing activities
35(179)Net increase in cash and cash equivalents1,2041,518Cash and cash equivalents at beginning of year8,4616,943Cash and cash equivalents at end of year$
9,665$
8,461Cash paid for taxes$
21$
24Supplemental non-cash items: Share value received for stock option exercise
$
-$
89 Share value issued for lon
'/>"/>
| SOURCE MGC Diagnostics Corporation Copyright©2012 PR Newswire. All rights reserved |